TQ Quiz | Neurotrophic Keratitis & Thyroid Eye Disease Key Disorders, Management Strategies, and Understanding the Role of Biologic Therapies (Orlando 2025) by Events@optometricedu.com | May 14, 2025 | 2025 Orlando, TQ Courses | 0 comments "*" indicates required fields This field is hidden when viewing the formDate (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent 90 days past date (Hidden) MM slash DD slash YYYY This field is hidden when viewing the formEvent Date Difference (Hidden)1. Which class of drugs are produced using a living system, such as a microorganism, plant cell, or animal cell?* A - Opioid drugs B - Analgesic drugs C - Antiviral drugs D - Biologic drugs 2. The manufacturing process of a biologic drug is closest to ______________?* A - Organic chemistry B - Genetic engineering C - Inorganic chemistry D - Analytical chemistry 3. When comparing the size of a chemically synthesized drug to a biologic drug, generally biologics are ___________________________?* A - much smaller the new nanotechnology B - generally slightly smaller C - the same size as chemically synthesized drugs D - larger in size 4. When comparing the complexity of a chemically synthesized drug to a biologic drug, which of the following is true?* A - Biologics are more complex B - Biologics and chemically synthesized drugs are equally complex C - Biologics are slightly less complex D - Biologics are simple molecules 5. Most biologic drugs are given________?* A - orally B - sublingually C - as an injection or infusion D - rectally 6. Which term most closely fits the following definition: “A biologic medical product, also known as a biologic that is highly similar to another already approved biologic medicine or the reference medicine”?* A - Generic medication B - All-purpose biologic C - Copycat biologic D - Biosimilar drug 7. Which of the following ocular biologic drugs is NOT indicated for the treatment of neovascular (wet) age-related macular degeneration?* A - Bevacizumab (Avastin) B - Teprotumumab-trbw (Tepezza) C - Brolucizumab-dbll (Beovu) D - Ranibizumab (Lucentis) 8. Which biologic drug is an injection and is used for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), it offers a 3-month dosing schedule in the first year of treat, but when used resulted in an adverse intraocular inflammation events?* A - Bevacizumab (Avastin) B - Ranibizumab (Lucentis) C - Aflibercept (Eylea) D - Brolucizumab-dbll (Beovu) 9. Which biologic drug is the first ophthalmology biosimilar approved by US-FDA? It is indicated to treat wet AMD, Macular Edema following RVO, and myopic CNVM,* A - Bevacizumab (Avastin) B - Ranibizumab (Lucentis) C - Ranibizumab-nuna (Byooviz) D - Aflibercept (Eylea) 10. The best in office diagnostic procedure to diagnose neurotrophic keratitis is:* A - Optical coherence tomography (OCT) B - Corneal sensitivity testing C - Visual field 24-2 sita standard D - Corneal topography 11. Which ocular biologic drug is indicated for the treatment of neurotrophic keratitis?* A - Teprotumumab-trbw (Tepezza) B - Cenegermin–bkbj (Oxervate) C - Tocilizumab (Actemra) D - Adalimumab (Humira) 12. Which ocular biologic drug is indicated for eye care and is the only one administrated as an eye drop?* A - Teprotumumab-trbw (Tepezza) B - Cenegermin –bkbj (Oxervate) C - Tocilizumab (Actemra) D - Adalimumab (Humira) 13. Which of the following mechanisms most closely describes how cenegermin–bkbj (Oxervate) works?* A - It binds to IGF-1 receptor and blocks its activation and signaling B - It is a recombinant form of human nerve growth factor C - It blocks vascular endothelial growth factor D - It binds to TNF and blocks its action in the body 14. Which in office treatment or procedure has shown to be beneficial for treating neurotrophic keratitis:* A - Glaucoma drops with BAK B - Photorefractive Keratectomy (PRK) C - Cornea crosslinking D - Amniotic membrane 15. What is the most common cause of thyroid dysfunction?* A - Cancer B - Autoimmune disease C - Surgically induced D - Pregnancy E - Medication toxicity or side effect 16. Which of the following causes the thyroid eye disease in the congestive autoimmune form phase?* A - Thyroid antibodies B - Triiodothyronine (T3) C - Thyroxine (T4) D - Calcitonin 17. Which grading scale grades severity and activity? Also used in the clinical trials and studies for Teprotumumab-trbw (Tepezza).* A - NOSPECS grading system B - YESSPECS grading system C - LEMO classification D - Clinical Activity Score (CAS) 18. Which biologic drug is indicated for thyroid eye disease?* A - Teprotumumab-trbw (Tepezza) B - Cenegermin–bkbj (Oxervate) C - Tocilizumab (Actemra) D - Adalimumab (Humira) 19. The mechanism of action of Teprotumumab-trbw (Tepezza) is?* A - Antibiotic B - Antiviral C - Increased uveal scleral outflow D - Immunomodulary 20. Which of the following mechanisms most closely describes how Teprotumumab-trbw (Tepezza) works?* A - It binds to IGF-1 receptor and blocks its activation and signaling B - It is an exact copy human nerve growth factor C - It blocks vascular endothelial growth factor D - It binds to TNF and blocks its action in the body Personal InformationName* First Last Email* Phone*OE Tracker #License #Address* Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands, BritishVirgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands Country Payment InformationPromotional CodeOrlando 2025 - Neurotrophic Keratitis & Thyroid Eye Disease Key Disorders, Management Strategies, and Understanding the Role of Biologic Therapies*After 90 days, pricing will increase to $30. Price: Retake Discount Price: Promotional Discount Price: Credit Card* This field is hidden when viewing the formCourse Information (HIDDEN)This field is hidden when viewing the formCourse Name (HIDDEN)This field is hidden when viewing the formRetake Code (HIDDEN)This field is hidden when viewing the formQuiz URL (HIDDEN)Do not include ending backslash (aka no .com/)This field is hidden when viewing the formCE Hours Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website
